Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Dermatol ; 42(4): 355-359, 2024.
Article in English | MEDLINE | ID: mdl-38281688

ABSTRACT

Herpes zoster ophthalmicus (HZO) occurs when latent varicella zoster virus reactivates in the ophthalmic division of the fifth cranial nerve (CNV1). HZO commonly affects older and immunocompromised patients. This disease is considered an ophthalmic emergency due to the wide range of associated ocular symptoms, including severe chronic pain and vision loss. HZO is typically a clinical diagnosis due to its classic presentation of a unilateral vesicular eruption in the dermatomes corresponding to CNV1. Timely treatment is imperative to minimize ocular morbidity in HZO, given that ocular involvement is present in 50% of affected patients.


Subject(s)
Antiviral Agents , Herpes Zoster Ophthalmicus , Humans , Herpes Zoster Ophthalmicus/diagnosis , Herpes Zoster Ophthalmicus/drug therapy , Herpes Zoster Ophthalmicus/complications , Antiviral Agents/therapeutic use , Herpesvirus 3, Human , Acyclovir/therapeutic use , Immunocompromised Host
SELECTION OF CITATIONS
SEARCH DETAIL
...